journal
https://read.qxmd.com/read/38423342/successful-treatment-of-a-kidney-transplant-patient-with-severe-novel-coronavirus-pneumonia-a-case-report
#21
Shuang Li, Tao Feng, Xingliang Hao, Yingying Wang, Jian Zhang
The high infection rate and mortality associated with novel coronavirus infections have attracted worldwide attention; however, the impact of the novel coronavirus on patients with a history of renal transplantation has not been investigated thoroughly. This report presents a patient with SARS-CoV-2 pneumonia following kidney transplantation. The patient developed acute respiratory distress syndrome and acute renal failure upon infection. Following a treatment regimen consisting of discontinued immunosuppressant use and low-dose methylprednisolone-based therapy, the patient successfully recovered and her renal function returned to normal...
February 27, 2024: Transplant Immunology
https://read.qxmd.com/read/38403198/micro-vascular-complications-of-post-transplant-diabetes-mellitus-in-renal-transplant-recipients-an-observational-study
#22
JOURNAL ARTICLE
Abdullah, Indrajeet Momin, Anupma Kaul, Dharmendra Bhaduaria, Narayan Prasad, Manas Behera, Manas Patel, Ravi Kushwaha, Monika Yachha, Aneesh Srivastava
INTRODUCTION: The incidence of post-transplant diabetes mellitus (PTDM) ranges from 2.5% to 20% in kidney transplant recipients. Diabetic retinopathy (DR), diabetic kidney disease (DKD), and distal symmetric polyneuropathy (DSPN) are the microvascular complications frequently seen in both type 1 and 2 diabetes mellitus (DM). However, the data regarding these complications in patients with PTDM is lacking. METHOD: A retrospective and prospective observational study of PTDM conducted at a tertiary care hospital from November 2018 to December 2020...
February 23, 2024: Transplant Immunology
https://read.qxmd.com/read/38403197/role-of-hla-matching-and-donor-specific-antibody-development-in-long-term-survival-acute-rejection-and-cardiac-allograft-vasculopathy
#23
JOURNAL ARTICLE
Dario Costa, Antonietta Picascia, Vincenzo Grimaldi, Cristiano Amarelli, Andrea Petraio, Anna Levi, Mario Di Donato, Anna Virginia Adriana Pirozzi, Carmela Fiorito, Giusi Moccia, Aurora Gallo, Mariagrazia Strozziero, Claudio Marra, Marisa De Feo, Francesco Cacciatore, Ciro Maiello, Claudio Napoli
Although there are different data supporting benefits of HLA matching in kidney transplantation, its role in heart transplantation is still unclear. HLA mismatch (MM) between donor and recipient can lead to the development of donor-specific antibodies (DSA) which produces negative events on the outcome of heart transplantation. Moreover, DSAs are involved in the development of antibody-mediated rejection (AMR) and are associated with an increase in cardiac allograft vasculopathy (CAV). In this study it is analyzed retrospectively the influence of HLA matching and anti-HLA antibodies on overall survival, AMR and CAV in heart transplantation...
February 23, 2024: Transplant Immunology
https://read.qxmd.com/read/38395087/long-term-remission-of-infantile-takayasu-arteritis-associated-with-germline-cbl-syndrome-after-allogeneic-hematopoietic-stem-cell-transplantation-a-case-report-and-literature-review
#24
Elizabeth Munoz-Osores, Mervin Piñones, Francisco Barriga, María Angélica Wietstruck, Guillermo Pérez-Mateluna, Cecilia Mellado, Mariana Aracena, Rodrigo Parra, Cristián García, Arturo Borzutzky
Takayasu arteritis (TA) is a large-vessel vasculitis that rarely presents in infancy. Casitas B-lineage lymphoma (CBL) syndrome is a rare genetic disorder due to heterozygous CBL gene germline pathogenic variants that is characterized by a predisposition to develop juvenile myelomonocytic leukemia (JMML). Vasculitis, including TA, has been reported in several patients. Herein, we describe a patient with CBL syndrome, JMML, and TA, developing long-term remission of this vasculitis after allogeneic hematopoietic stem cell transplant (HSCT), and perform a literature review of CBL syndrome with vasculitis or vasculopathy...
February 22, 2024: Transplant Immunology
https://read.qxmd.com/read/38395088/conversion-from-twice-daily-everolimus-to-once-daily-sirolimus-in-long-term-stable-liver-transplant-recipients
#25
JOURNAL ARTICLE
Jérôme Dumortier, Olivier Boillot
BACKGROUND: After organ transplantation, strategies for simplifying the therapeutic regimen may improve adherence and prevent acute organ rejection and/or late graft loss. The present study aimed to evaluate the safety and efficacy of conversion from everolimus (EVR) twice daily to sirolimus (SIR) once daily in a large cohort of liver transplantation (LT) patients. METHODS: Were included 108 LT patients with at least 12 months of post-transplant follow-up and no rejection episodes in the last year...
February 21, 2024: Transplant Immunology
https://read.qxmd.com/read/38342329/h-2-s-alleviates-renal-ischemia-and-reperfusion-injury-by-suppressing-ers-induced-autophagy
#26
JOURNAL ARTICLE
Sujuan Feng, Jiawei Ji, Han Li, Xiaodong Zhang
BACKGROUND: Ischemia/reperfusion injury (IRI) can lead to acute kidney injury and result in high disability and mortality rates. Cystathionine γ-lyase (CSE)-produced hydrogen sulfide (H2 S) has been confirmed to play a protective role in renal IRI. While autophagy is involved in renal IRI, its role in the regulation by endoplasmic reticulum stress (ERS) has not been considered. Our study explored the role of CSE/H2 S in protecting against renal IRI by regulating ERS-induced autophagy...
February 9, 2024: Transplant Immunology
https://read.qxmd.com/read/38342328/retrospective-analysis-on-incidence-and-risk-factors-of-post-transplant-diabetes-mellitus-after-lung-transplantation-and-its-association-with-clinical-outcomes
#27
JOURNAL ARTICLE
Wenwen Du, Xiaoxing Wang, Dan Zhang, Xianbo Zuo
BACKGROUND: Post-transplant diabetes mellitus (PTDM) is a common complication after transplantation. We aim to explore potential risk factors of PTDM and its association with outcomes after lung transplantation (LTx). METHODS: A retrospective study was conducted in 100 patients who underwent LTx at our institution from 2017 to 2021. Patients' information was collected, and genotyping for single nucleotide polymorphisms known to potentially increase the risk of Type 2 DM was performed...
February 9, 2024: Transplant Immunology
https://read.qxmd.com/read/38325526/protective-effects-and-mechanisms-of-dapagliflozin-on-renal-ischemia-reperfusion-injury
#28
JOURNAL ARTICLE
Qiuxiao-Zhu, Huiyao-Hao, Na Li, Zibo-Liu, Qian-Wang, Linyi-Shu, Lihui-Zhang
BACKGROUND: Renal diseases have a significant negative impact on human health and the quality of life. Renal ischemia/reperfusion (I/R) injury is considered as one of the leading causes of renal dysfunction and tissue damage. Oxidative stress and inflammation are responsible for cellular apoptosis playing critical roles in renal I/R injury. Recent studies suggested that dapagliflozin-a medication used to treat Type 2 Diabetes-may exert protective effects on I/R injury in kidneys by alleviating oxidative stress and inflammation...
February 5, 2024: Transplant Immunology
https://read.qxmd.com/read/38325525/three-year-outcomes-of-de-novo-tacrolimus-extended-release-tablets-lcpt-compared-to-twice-daily-tacrolimus-in-adult-heart-transplantation
#29
JOURNAL ARTICLE
Amit Alam, Johanna S van Zyl, Raksha Patel, Aayla K Jamil, Joost Felius, Sandra A Carey, Robert L Gottlieb, Cesar Y Guerrero-Miranda, Parag Kale, Shelley A Hall, Teena Sam
BACKGROUND: Extended-release tacrolimus for prophylaxis of allograft rejection in heart transplant (HT) recipients is currently not FDA-approved. One such extended-release formulation of tacrolimus known as LCPT allows once-daily dosing and improves bioavailability compared to immediate-release (IR-) tacrolimus. We compared long-term efficacy and safety of LCPT to IR-tacrolimus applied de novo in adult OHT recipients. METHODS: 25 prospective recipients on LCPT at our center from 2017 to 2019 were matched 1:2 with historical control recipients treated with IR-tacrolimus based on age, gender, and baseline creatinine...
February 5, 2024: Transplant Immunology
https://read.qxmd.com/read/38307154/hemophagocytic-lymphohistiocytosis-after-solid-organ-transplantation-a-challenge-for-clinicians
#30
REVIEW
Shanshan Xu, Kang He
Hemophagocytic lymphohistiocytosis (HLH) is a rare inflammatory disorder with a high mortality rate and a wide range of symptoms. Solid organ transplantation, which provides patients with a unique immunosuppressive state, is a less common predisposing factor for HLH. HLH after solid organ transplantation (HLH-SOT) is very rare and fatal. It is hard to diagnose and treat and extremely understudied. The use of immunosuppressants makes the situation of HLH-SOT more complex. This review summarizes the existing literature on HLH after solid organ transplantation and describes its triggers and symptoms, focusing on its diagnosis and treatment...
February 1, 2024: Transplant Immunology
https://read.qxmd.com/read/38302005/efficacy-and-safety-in-early-application-of-ruxolinitib-for-high-risk-acute-lymphoblastic-leukemia-to-prevent-gvhd-and-recurrence-after-allogeneic-hematopoietic-stem-cell-transplantation
#31
JOURNAL ARTICLE
Qian Cheng, Yishu Tang, Feiyang Liu, Xin Li, Dan Fang
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been identified as the potentially curative treatment for high-risk acute lymphoblastic leukemia (ALL) in adult patients. However, relapse of the disease and/or development of graft-versus-host disease (GVHD) remain to be the most common barriers for successful allo-HSCT. Preclinical studies showed that ruxolitinib, a Janus tyrosine kinase (Jak)1 and Jak2 inhibitor, has a selective anti-GVHD effects while preserving a potent graft-versus-leukemia (GVL) effect...
January 30, 2024: Transplant Immunology
https://read.qxmd.com/read/38286299/interleukin-10-gcc-gcc-haplotype-is-associated-high-risk-of-acute-gvhd-in-patients-undergoing-allogeneic-hsct-in-the-southern-of-brazil
#32
JOURNAL ARTICLE
Mariela Granero Farias, Camila Andrade Dos Santos, Alessandra Aparecida Paz, Liane Esteves Daudt
INTRODUCTION: Hematopoietic Stem Cell Transplant (HSCT) is currently an important curative treatment for many patients with malignant and non-malignant diseases. Graft versus host disease (GVHD) represents a major complication in allogeneic HSCT recipients. Several polymorphisms in cytokine genes have recently been investigated as candidates for risk factors for acute-GVHD (aGVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). OBJECTIVE: In this study, we analyzed specific interleukin (IL)-10 haplotypes polymorphisms, in a cohort of 99 patients and their respective allo-HSCT donors for aGVHD and risk...
January 27, 2024: Transplant Immunology
https://read.qxmd.com/read/38184214/effect-of-gvhd-on-the-gut-and-intestinal-microflora
#33
REVIEW
Hao Ji, Shuai Feng, Yuan Liu, Yue Cao, HuiQuan Lou, Zengzheng Li
Graft-versus-host disease (GVHD) is one of the most important cause of death in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The gastrointestinal tract is one of the most common sites affected by GVHD. However, there is no gold standard clinical practice for diagnosing gastrointestinal GVHD (GI-GVHD), and it is mainly diagnosed by the patient's clinical symptoms and related histological changes. Additionally, GI-GVHD causes intestinal immune system disorders, damages intestinal epithelial tissue such as intestinal epithelial cells((IEC), goblet, Paneth, and intestinal stem cells, and disrupts the intestinal epithelium's physical and chemical mucosal barriers...
February 2024: Transplant Immunology
https://read.qxmd.com/read/38272322/nephrotic-proteinuria-and-hematuria-with-newly-diagnosed-iga-nephropathy-after-liver-transplant-a-case-report
#34
Tingli Wang, Honghong Ren, Dan Yin, Hongyu Qiu
BACKGROUND: IgA nephropathy is a renal lesion in patients with end-stage liver disease, called hepatic IgA nephropathy. The common manifestation of hepatic IgA nephropathy is microscopic hematuria. Sirolimus, often used to prevent organ rejection, has been reported to induce proteinuria after organ transplantation. But few cases of nephrotic proteinuria and hematuria are reported. CASE PRESENTATION: In this case, a 45-year-old male with a long history of hepatic B virus infection and liver cirrhosis, received liver transplant and was taking sirolimus as one of his immunosuppression drugs...
January 23, 2024: Transplant Immunology
https://read.qxmd.com/read/38266883/exploration-of-the-shared-gene-signatures-and-biological-mechanisms-between-ischemia-reperfusion-injury-and-antibody-mediated-rejection-in-renal-transplantation
#35
JOURNAL ARTICLE
Shan Jiang, Hua Su
BACKGROUND: Antibody-mediated rejection (ABMR) plays a crucial role in graft loss during allogeneic renal transplantation. In renal transplantation, ischemia-reperfusion injury (IRI) is unavoidable, serves as a major contributor to acute rejection, and is linked to graft loss. However, the mechanisms underlying IRI and ABMR are unclear. Therefore, this study aimed to investigate the shared genetic characteristics and biological mechanisms between IRI and ABMR. METHODS: Gene expressions for IRI (GSE43974) and ABMR (GSE129166 and GSE36059) were retrieved from the Gene Expression Omnibus database...
January 22, 2024: Transplant Immunology
https://read.qxmd.com/read/38262540/probiotics-gut-microbiome-and-cardiovascular-diseases-an-update
#36
REVIEW
Laura Dosh, Maya Ghazi, Karim Haddad, Jad El Masri, Jihad Hawi, Angelo Leone, Charbel Basset, Alice Gerges Geagea, Rosalyn Jurjus, Abdo Jurjus
Cardiovascular diseases (CVD) are one of the most challenging diseases and many factors have been demonstrated to affect their pathogenesis. One of the major factors that affect CVDs, especially atherosclerosis, is the gut microbiota (GM). Genetics play a key role in linking CVDs with GM, in addition to some environmental factors which can be either beneficial or harmful. The interplay between GM and CVDs is complex due to the numerous mechanisms through which microbial components and their metabolites can influence CVDs...
January 21, 2024: Transplant Immunology
https://read.qxmd.com/read/38242727/retraction-notice-to-inhibition-of-mir-495-3p-ameliorated-sevoflurane-induced-damage-through-bdnf-erk-creb-signaling-pathways-in-ht22-cells-transplant-immunology-volume75-december-2022-101708
#37
Xiaomei Chen, Chongyi Li, Rui Zeng, Ling Qiu, Jianhang Huang, Ning Wang, Xia Ren, Xingwu Lin
No abstract text is available yet for this article.
January 18, 2024: Transplant Immunology
https://read.qxmd.com/read/38224843/renal-transplantation-for-infantile-and-juvenile-cystinosis-two-case-report-and-review-of-the-literature
#38
Karen El Ghoul, Dany Akiki, Nagi Nawfal, Maroun Abou Jaoude
Cystinosis is a rare autosomal recessive lysosomal storage disorder characterized by cystine buildup in various tissues, including the kidneys. Renal involvement is the primary manifestation, leading to end-stage renal disease (ESRD) if left untreated. Kidney transplantation (KT) in patients with cystinosis has significantly improved their prognosis for the disease outcome. Detailed reports on preoperative and Long-term postoperative management in these patients remain sparse. This report discusses the outcomes of two young adult patients of Middle Eastern descent with cystinosis who underwent KT...
January 14, 2024: Transplant Immunology
https://read.qxmd.com/read/38218230/upregulation-of-ido-gene-expression-reduces-the-immunogenicity-of-epidermal-cells-and-strengthens-the-immune-protection-of-epidermal-cells-during-transplantation-treatment-of-wounds
#39
JOURNAL ARTICLE
Kun Zhang, Xinzhu Liu, Peng Luo, Zhisheng Li, Hongqing Zhao, Dawei Li, Zhaoxing Liu, Bohan Zhang, Chuanan Shen
BACKGROUND: Epidermal cell transplantation is a feasible treatment option for large wounds; however, sources of autologous epidermal cells are often limited. Allogeneic epidermal cells can be cultured conveniently; however, related immune rejection needs to be addressed. Herein, we hypothesized that the immunogenicity of epidermal cells with high indoleamine 2,3-dioxygenase (IDO) expression may be reduced by gene transfection. METHODS/RESULTS: To test this hypothesis, we obtained stable transfectants by transfecting epidermal stem cells with a lentiviral vector encoding the IDO gene and screening them for puromycin resistance (a marker for successful transfection)...
January 11, 2024: Transplant Immunology
https://read.qxmd.com/read/38218229/the-role-of-hyperleptinaemia-and-low-values-of-interleukin-10-in-de-novo-dsa-production-after-kidney-transplantation
#40
JOURNAL ARTICLE
Ivana Dedinská, Daniela Kantárová, Katarína Macháleková, Karol Graňák, Matej Vnučák, Marián Mokáň
BACKGROUND: White adipose tissue secretes a number of peptide hormones. The aim of this paper was to determine the role of leptin, adiponectin and interleukin-10 and interleukin-6 on the development of graft rejection in protocol biopsy after kidney transplantation. METHODS: In a prospective analysis (n = 104), we monitored the values of leptin, adiponectin, IL-6, and IL-10 prior to the transplantation and in the 3rd month after the transplantation...
January 11, 2024: Transplant Immunology
journal
journal
31390
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.